Grail only 18% Stage 1 and 43% Stage 2 I recently saw someone on CEO. ca talking about Grail. I mean come on they are less than 50% detecting cancers up to Stage 2 and yet look at their market value and all the marketing and hype they get.
18% at Stage 1 and 43% for Stage 1 and 2. Come on.
Stagezero's (detecting cancers at Stage 0) time will come.
https://www.oncodna.com/en/company/activity/news-list/cancer-screening-early-detection-a-methylation-based-ctdna-assay-from-grail-delivered-sensitivity-93-for-stage-iv-cancer-falling-to-43-for-stage-ii-and-18-for-stage-i-disease/